TOTIPHARMACEUTICAL

Indicaton

Polypharmacology for all therapeutic aeras using nano-drug delivery systems

Therapeutic indications

Type of product

Small molecule

Table

Phase

Discovery
Available in

EU

Keep browsing

You may also be interested in

Proclarix

Proclarix® is CE marked, intended for in vitro diagnostic use and indicated for prostate cancer diagnosis in patients with normal digital rectal exam (DRE), enlarged prostate volume and elevated levels of PSA at 2-10 ng/ml.

Marketed

Dimiracetam

Management of acute and chronic symptoms of chemotherapy-induced sensory peripheral neuropathy.

Phase II started

Dicholine succinate (DISU) nasal spray

chronic rhinosinusitis (CRS)

Phase II completed